Cargando…
Clinical proteomic biomarkers: relevant issues on study design & technical considerations in biomarker development
Biomarker research is continuously expanding in the field of clinical proteomics. A combination of different proteomic–based methodologies can be applied depending on the specific clinical context of use. Moreover, current advancements in proteomic analytical platforms are leading to an expansion of...
Autores principales: | Frantzi, Maria, Bhat, Akshay, Latosinska, Agnieszka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3994249/ https://www.ncbi.nlm.nih.gov/pubmed/24679154 http://dx.doi.org/10.1186/2001-1326-3-7 |
Ejemplares similares
-
Promise and Implementation of Proteomic Prostate Cancer Biomarkers
por: Latosinska, Agnieszka, et al.
Publicado: (2018) -
Omics Derived Biomarkers and Novel Drug Targets for Improved Intervention in Advanced Prostate Cancer
por: Frantzi, Maria, et al.
Publicado: (2020) -
Molecular Changes in Tissue Proteome during Prostate Cancer Development: Proof-of-Principle Investigation
por: Latosinska, Agnieszka, et al.
Publicado: (2020) -
Technical considerations in PCR-based assay design for diagnostic DNA methylation cancer biomarkers
por: Massen, Maartje, et al.
Publicado: (2022) -
Proteomic Workflows for Biomarker Identification Using Mass Spectrometry — Technical and Statistical Considerations during Initial Discovery
por: Orton, Dennis J., et al.
Publicado: (2013)